First phase of pharmacare must not ‘create new gaps’ in existing coverage, say lobbyists

Legislation recently rolled out to create universal pharmacare in Canada came as a welcome step forward for some advocacy groups, but concerns about issues such as the make-up of the national drug formulary will form the basis of some lobbying activity as the bill progresses...
SPONSORED CONTENT
Get Today’s Headlines Newsletter
Your quick scan of the news you need each weekday to be the smartest person in the room.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy











